AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Apr 16, 2024
35599_dirs_2024-04-15_d96c2d28-7e46-4ca4-a13e-116ecd0b5eb9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-04-15
Reporting Person: RALLIS CHRIS A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-15 | Common Shares | S | 800 | $10.45 | Disposed | 44449 | Direct |
| 2024-04-15 | Common Shares | M | 1389 | $10.45 | Acquired | 45838 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | Common Shares | $3.60 | M | 1389 | Disposed | 2024-05-15 | Options (1389) | Direct |
Footnotes
F1: Shares sold to satisfy tax obligation on option exercise.
F2: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
F3: Represents options exercised pursuant to a 10b5-1 program adopted August 17, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20